ストックスクリーナーアプリを入手
6.85
8.73%
0.55
Mannkind Corp (MNKD) 最新ニュース
MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
MannKind (NASDAQ:MNKD) pulls back 3.8% this week, but still delivers shareholders fantastic 36% CAGR over 5 years - Yahoo Finance
MannKind (NASDAQ:MNKD) Trading Up 5.7%Here's Why - MarketBeat
MannKind (NASDAQ:MNKD) Upgraded to Outperform at Royal Bank of Canada - MarketBeat
Tyvaso DPI royalties and pipeline potential boost MannKind stock—RBC - Investing.com
Noteworthy Wednesday Option Activity: MNKD, BTU, FSLR - Nasdaq
MannKind (NASDAQ:MNKD) Shares Gap UpShould You Buy? - MarketBeat
MannKind to issue shares in debt exchange deal - Investing.com
MannKind trims debt with $194 million note exchange - Investing.com
MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash - Yahoo Finance
HighTower Advisors LLC Buys 107,560 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Stock Price Down 5.4%Here's Why - MarketBeat
MannKind Becomes Oversold (MNKD) - Nasdaq
Wellington Management Group LLP Acquires 85,977 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®) - Barchart
Mannkind Corp (MNKD-Q) QuotePress Release - The Globe and Mail
The Manufacturers Life Insurance Company Grows Stake in MannKind Co. (NASDAQ:MNKD) - Defense World
Cipla’s ‘inhaled insulin’ from US’ MannKind Corp adds a ‘layer of convenience’ for those with diabetes - BusinessLine
CDSCO approves Cipla to distribute, market inhaled insulin in India - Daijiworld.com
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India - Yahoo Finance
Two Sigma Advisers LP Buys 1,000,600 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Cut to "Hold" at StockNews.com - MarketBeat
MannKind Co. (NASDAQ:MNKD) Stock Holdings Increased by BNP Paribas Financial Markets - MarketBeat
MannKind Co. (NASDAQ:MNKD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Jacobs Levy Equity Management Inc. Makes New $12.25 Million Investment in MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind Co. (NASDAQ:MNKD) Holdings Lifted by Parkman Healthcare Partners LLC - MarketBeat
MannKind (NASDAQ:MNKD) Upgraded by StockNews.com to Buy Rating - MarketBeat
Insider Sell Alert: Steven Binder Sells 67,536 Shares of MannKin - GuruFocus.com
MannKind director Steven Binder sells $465k in stock By Investing.com - Investing.com Nigeria
MannKind director Steven Binder sells $465k in stock - Investing.com India
MannKind (NASDAQ:MNKD) Downgraded to Hold Rating by StockNews.com - Defense World
Principal Financial Group Inc. Purchases 134,937 Shares of MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind Co. (NASDAQ:MNKD) Shares Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
MannKind (STU:NNFN) Inventories, Raw Materials & Components : €5.8 Mil (As of Sep. 2024) - GuruFocus.com
MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN
MannKind Corp director Steven Binder sells $456,563 in stock - Investing.com India
MannKind Corp director Steven Binder sells $456,563 in stock By Investing.com - Investing.com Nigeria
Insulin Pump Market Report 2024-2035, Featuring Profiles of Leading Players Including Beta Bionics, CeQur, EOFlow, Insulet, LA Roche, MannKind, Medtronic, Medtrum Technologies and MicroPort - Yahoo Finance
MannKind Corporation (NASDAQ:MNKD) Q3 2024 Earnings Call Transcript - Insider Monkey
MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Insider Sale: Chief People & Workpl Officer Stuart Tross Sells 5 - GuruFocus.com
MannKind Corp's chief people officer Stuart Tross sells $403,700 in stock - Investing.com Australia
Earnings call: MannKind sees growth and pipeline progress in Q3 2024 - Investing.com
MannKind Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Quantisnow
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Re - GuruFocus.com
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
MannKind (MNKD) Q3 2024 Earnings Call Transcript - Yahoo! Voices
MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
MannKind Corp Q3 2024 Earnings: EPS of $0.04 Beats Estimates, Re - GuruFocus.com
MannKind (MNKD) Matches Q3 Earnings Estimates - Yahoo Finance
MannKind: Q3 Earnings Snapshot - Thehour.com
MannKind Q3 Revenue Soars 37% to $70M, Driven by Strong Tyvaso DPI Growth - StockTitan
MannKind stock soars to 52-week high, hits $7.38 - Investing.com
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):